文献速递腹部CT

增强CT定性定量分析鉴别胰腺神经内分泌肿瘤分级的多中心研究

Qualitative and quantitative analysis of enhanced computed tomography in differentiating and grading pancreatic neuroendocrine neoplasms: a multicenter study.
PubMed 文献 · Abdom Radiol (NY) · 2026-01-19

该多中心研究纳入241例胰腺神经内分泌肿瘤患者,按2022 WHO分类复核病理诊断。研究分析增强CT的定性征象与定量参数,发现肿瘤部位、胰周血管受累、囊变坏死等定性指标有助于区分G1级肿瘤,而门静脉期比值等定量参数在鉴别胰腺神经内分泌癌中作用更显著。

要点

  • 肿瘤位于胰体尾部、无胰周血管受累、无囊变坏死时更倾向G1级pNET。
  • 门静脉期比值每升高0.1,诊断为pNEC的可能性显著降低。
  • 年龄增大是pNEC的独立预测因素,阅片时需结合患者年龄综合判断。

核心结论

  • 肿瘤部位、胰周血管受累、囊变或坏死改变等定性指标对区分G1级pNET具有关键作用。
  • 门静脉期比值等定量参数在鉴别pNEC方面更为重要。
  • 肿瘤大小每增加1 cm,诊断为G1级的概率降低(OR=0.60,95% CI:0.50-0.83,p=0.023)。
  • 胰周血管受累时诊断为G1级的可能性显著降低(OR=0.13,95% CI:0.06-0.48,p=0.005)。
  • 囊变或坏死改变存在时诊断为G1级的概率降低(OR=0.24,95% CI:0.07-0.83,p=0.036)。

研究设计与样本

  • 多中心研究,共纳入241例胰腺神经内分泌肿瘤患者。
  • 所有病理诊断按照2022年WHO内分泌与神经内分泌肿瘤分类进行复核。
  • 评估的CT影像特征包括大小、部位、形态、胰管远端扩张、血管受累、均匀性、囊变或坏死、清晰度、钙化。
  • 定量参数包括肿瘤HU值、胰腺实质HU值、动脉期比值和门静脉期比值。
  • 采用单因素和多因素分析,分别在G1与G2/G3/NEC之间以及NET与NEC之间进行比较。

关键影像表现/征象

  • 肿瘤位于胰头颈部时诊断为G1级的概率低于胰体尾部(OR=0.39,95% CI:0.17-0.61,p<0.001)。
  • 囊变或坏死改变在G1级病变中更少见,其存在提示非G1级可能。
  • 胰周血管受累在G1级病变中显著少见,提示更高级别或NEC可能。

诊断标准与关键数值

  • 肿瘤大小每增加1 cm,诊断G1的OR=0.60(95% CI:0.50-0.83,p=0.023)。
  • 肿瘤位于头颈部相对于体尾部的OR=0.39(95% CI:0.17-0.61,p<0.001),头颈部更不支持G1。
  • 胰周血管受累相对于无受累的OR=0.13(95% CI:0.06-0.48,p=0.005),血管受累强烈不支持G1。
  • 囊变或坏死改变相对于无改变的OR=0.24(95% CI:0.07-0.83,p=0.036),存在时提示非G1。
  • 鉴别pNEC的独立因素中,年龄OR=1.08(95% CI:1.02-1.14,p=0.017)。

临床应用与阅片要点

  • 阅片时应重点关注肿瘤部位、胰周血管是否受累以及有无囊变或坏死,这些征象对判断G1级pNET具有独立预测价值。
  • 报告建议记录门静脉期肿瘤与胰腺实质的比值,该参数对鉴别pNEC有独立意义。
  • 患者年龄应作为影像判读的辅助信息,年龄越大需警惕pNEC可能。
  • 胰头颈部病变即使形态学看似惰性,也应提高对非G1级病变的警惕。

局限性

  • 研究为多中心设计,但具体中心数未在摘要中明确报告。
  • 未报告CT设备型号与扫描协议的统一性,可能影响定量参数的普适性。
  • 摘要未提供G2与G3之间的独立鉴别分析结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Accurate preoperative differentiating and grading of pancreatic neuroendocrine neoplasms (pNENs) is crucial. This study aims to explore the efficacy of Computed Tomography (CT) in distinguishing Grade1 (G1) pancreatic neuroendocrine tumors (pNETs) and pancreatic neuroendocrine carcinomas (pNECs) from other pNENs before appropriate interventions.

METHODS: A total of 241 patients with pNENs were enrolled in this study. All pathological diagnoses were re-reviewed according to the 2022 WHO Classification of Endocrine and Neuroendocrine Tumours. CT image characteristics including size, location, morphology, distal pancreatic duct dilation, vascular involvement, homogeneity, cystic or necrotic change, conspicuity, calcification, the Hounsfield Unit (HU) value of the tumor and the parenchyma, arterial phase (AP) ratio and portal venous phase (PVP) ratio were assessed. Univariate and multivariate analyses were performed between G1 and G2/G3/NEC, and between NET and NEC.

RESULTS: Tumor size (per 1-cm increase; OR = 0.60, 95% CI: 0.50-0.83; p = 0.023), tumor location (head/neck vs. body/tail; OR = 0.39, 95% CI: 0.17-0.61; p < 0.001), peripancreatic vascular involvement (present vs. absent; OR = 0.13, 95% CI: 0.06-0.48; p = 0.005), cystic or necrotic changes (present vs. absent; OR = 0.24, 95% CI: 0.07-0.83; p = 0.036) were four independently associated features for predicting G1. Age (OR = 1.08, 95% CI: 1.02-1.14; p = 0.017) and PVP ratio (per 0.1 increase; OR = 0.43, 95% CI: 0.29-0.65; p = 0.021) were independent factors for differentiating pNECs.

CONCLUSION: Qualitative variables, particularly tumor location, peripancreatic vascular involvement, and cystic or necrotic changes, played a crucial role in distinguishing G1 pNETs. Quantitative variables, especially PVP ratio, were more significant in differentiating pNECs.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Song, Wei, Tan, et al. Qualitative and quantitative analysis of enhanced computed tomography in differentiating and grading pancreatic neuroendocrine neoplasms: a multicenter study. Abdom Radiol (NY). 2026. PMID: 41553527. doi:10.1007/s00261-026-05375-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。